Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological studyEric M. Reiman, Clinton T. Baldwin, Joseph F. Arboleda‐Velásquez et al.|Nature Communications|2020Cited by 493
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective StudyCarey E. Gleason, Sanjay Asthana, Genevieve Neal‐Perry et al.|PLoS Medicine|2015Cited by 481
Assessment of the genetic variance of late-onset Alzheimer's diseasePerry G. Ridge, David H. Cribbs, Kaitlyn B. Hoyt et al.|Neurobiology of Aging|2016Cited by 255
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseasePontus Erickson, Prashanthi Vemuri, Joel Simrén et al.|JAMA Neurology|2023Cited by 46
The cerebrospinal fluid A‐T+ Alzheimer disease biomarker profile: prevalence and clinical relevancePontus Eriksson, Henrik Zetterberg, Joel Simrén et al.|Alzheimer s & Dementia|2023Cited by 2